Identification and characterization of novel ERC-55 interacting proteins: Evidence for the existence of several ERC-55 splicing variants; including the cytosolic ERC-55-C

Proteomics

Volumn 9, Issue 23, 2009, Pages 5267-5287

  Ludvigsen, Maja ^a   Jacobsen, Christian ^a   Maunsbach, Arvid B ^a   Honoré, Bent ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Cell biology; CREC protein; Cytosol; Endoplasmic reticulum; ERC 55 variants; Protein protein interaction

Indexed keywords

CALCYCLIN; ENDOPLASMIC RETICULUM CALCIUM BINDING PROTEIN OF 55KDA; PROTEIN S 100; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING; CELL CYCLE REGULATION; CELL FRACTIONATION; CELL FUNCTION; CELL ORGANELLE; CONTROLLED STUDY; CYTOSKELETON; CYTOSOL; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOELECTRON MICROSCOPY; IN VITRO STUDY; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEOMICS;

AMINO ACID SEQUENCE; CALCIUM-BINDING PROTEINS; CELL CYCLE PROTEINS; CELL LINE; CYTOSOL; FEMALE; GENE EXPRESSION; HUMANS; KININOGENS; LACTOFERRIN; MOLECULAR SEQUENCE DATA; MURAMIDASE; PEPTIDES; PEROXIREDOXIN VI; PLACENTA; PREGNANCY; PROTEIN BINDING; PROTEIN SPLICING; S100 PROTEINS;

EID: 73249116586     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200900321     Document Type: Article

References (94)

1. Honoré, B., The rapidly expanding CREC protein family: members, localization, function, and role in disease. Bioessays 2009, 31, 262-277.
2. 2+-binding proteins localised to the secretory pathway of mammalian cells. FEBS Lett. 2000, 466, 11-18.
3. 2+-binding protein with multiple EF-hand motifs and a carboxyl-terminal HDEL sequence. J. Biol. Chem. 1993, 268, 699-705.
4. Weis, K., Griffiths, G., Lamond, A. I., The endoplasmic reticulum calcium-binding protein of 55 kDa is a novel EF-hand protein retained in the endoplasmic reticulum by a carboxyl-terminal His-Asp-Glu-Leu motif. J. Biol. Chem. 1994, 269, 19142-19150.
5. Tsuji, A., Kikuchi, Y., Sato, Y., Koide, S. et al. A proteomic approach reveals transient association of reticulocalbin-3, a novel member of the CREC family, with the precursor of subtilisin-like proprotein convertase, PACE4. Biochem. J. 2006, 396, 51-59.
6. 2+-binding protein localized to the Golgi lumen. J. Cell Biol. 1996, 133, 257-268.
7. 2+-binding protein with six EF-hand motifs. DNA Seq. 1997, 7, 217-220.
8. Lam, P. P., Hyvarinen, K., Kauppi, M., Cosen-Binker, L. et al. A cytosolic splice variant of Cab45 interacts with Munc18b and impacts on amylase secretion by pancreatic acini. Mol. Biol. Cell 2007, 18, 2473-2480.
9. 2+-binding protein retained in the endoplasmic reticulum with a novel carboxyl-terminal sequence, HDEF. J. Biol. Chem. 1997, 272, 18232-18239.
10. 2+-binding activity. Biochim. Biophys. Acta 1998, 1386, 121-131.
11. Vorum, H., Hager, H., Christensen, B. M., Nielsen, S., Honoré, B., Human calumenin localizes to the secretory pathway and is secreted to the medium. Exp. Cell Res. 1999, 248, 473-481.
12. Hseu, M. J., Yen, C. H., Tzeng, M. C., Crocalbin: a new calcium-binding protein that is also a binding protein for crotoxin, a neurotoxic phospholipase A2. FEBS Lett. 1999, 445, 440-444.
13. Cooper, C. R., Graves, B., Pruitt, F., Chaib, H. et al. Novel surface expression of reticulocalbin 1 on bone endothelial cells and human prostate cancer cells is regulated by TNF-alpha. J. Cell. Biochem. 2008, 104, 2298-2309.
14. Wallin, R., Hutson, S. M., Cain, D., Sweatt, A., Sane, D. C., A molecular mechanism for genetic warfarin resistance in the rat. FASEB J. 2001, 15, 2542-2544.
15. Wajih, N., Sane, D. C., Hutson, S. M., Wallin, R., The inhibitory effect of calumenin on the vitamin K-dependent gamma-carboxylation system. Characterization of the system in normal and warfarin-resistant rats. J. Biol. Chem. 2004, 279, 25276-25283.
16. 2+-binding protein, interacts with ryanodine receptor-1 in rabbit skeletal sarcoplasmic reticulum. Biochem. Biophys. Res. Commun. 2006, 343, 34-42.
17. Sahoo, S. K., Kim do, H., Calumenin interacts with SERCA2 in rat cardiac sarcoplasmic reticulum. Mol. Cells 2008, 26, 265-269.
18. Kimura, K., Wakamatsu, A., Suzuki, Y., Ota, T. et al. Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. Genome Res. 2006, 16, 55-65.
19. Gonzalez-Conejero, R., Corral, J., Roldan, V., Ferrer, F. et al. The genetic interaction between VKORC1 c1173t and calumenin a29809g modulates the anticoagulant response of acenocoumarol. J. Thromb. Haemost. 2007, 5, 1701-1706.
20. Chen, J. J., Reid, C. E., Band, V., Androphy, E. J., Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science 1995, 269, 529-531.
21. Vazquez-Ortiz, G., Garcia, J. A., Ciudad, C. J., Noe, V. et al. Differentially expressed genes between high-risk human papillomavirus types in human cervical cancer cells. Int. J. Gynecol. Cancer 2007, 17, 484-491.
22. Cavallo, F., Astolfi, A., Iezzi, M., Cordero, F. et al. An integrated approach of immunogenomics and bioinformatics to identify new Tumor Associated Antigens (TAA) for mammary cancer immunological prevention. BMC Bioinformatics 2005, 6 (Suppl 4), S7.
23. Imai, T., Matsuda, K., Shimojima, T., Hashimoto, T. et al. ERC-55, a binding protein for the papilloma virus E6 onco-protein, specifically interacts with vitamin D receptor among nuclear receptors. Biochem. Biophys. Res. Commun. 1997, 233, 765-769.
24. Kemmis, C. M., Salvador, S. M., Smith, K. M., Welsh, J., Human mammary epithelial cells express CYP27B1 and are growth inhibited by 25-hydroxyvitamin D-3, the major circulating form of vitamin D-3. J. Nutr. 2006, 136, 887-892.
25. Kemmis, C. M., Welsh, J., Mammary epithelial cell transformation is associated with deregulation of the vitamin D pathway. J. Cell. Biochem. 2008, 105, 980-988.
26. Bareis, P., Bises, G., Bischof, M. G., Cross, H. S., Peterlik, M., 25-Hydroxy-vitamin d metabolism in human colon cancer cells during tumor progression. Biochem. Biophys. Res. Commun. 2001, 285, 1012-1017.
27. Cross, H. S., Bareis, P., Hofer, H., Bischof, M. G., 25-Hydroxyvitamin D(3)-1alpha-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids 2001, 66, 287-292.
28. Anderson, M. G., Nakane, M., Ruan, X., Kroeger, P. E., Wu-Wong, J. R., Expression of VDR and CYP24A1 mRNA in human tumors. Cancer Chemother. Pharmacol. 2006, 57, 234-240.
29. Helbig, I., Matigian, N. A., Vadlamudi, L., Lawrence, K. M. et al. Gene expression analysis in absence epilepsy using a monozygotic twin design. Epilepsia 2008, 49, 1546-1554.
30. Dodds, D., Schlimgen, A. K., Lu, S. Y., Perin, M. S., Novel reticular calcium binding protein is purified on taipoxin columns. J. Neurochem. 1995, 64, 2339-2344.
31. Dodds, D. C., Omeis, I. A., Cushman, S. J., Helms, J. A., Perin, M. S., Neuronal pentraxin receptor, a novel putative integral membrane pentraxin that interacts with neuronal pentraxin 1 and 2 and taipoxin-associated calcium-binding protein 49. J. Biol. Chem. 1997, 272, 21488-21494.
32. Kirkpatrick, L. L., Matzuk, M. M., Dodds, D. C., Perin, M. S., Biochemical interactions of the neuronal pentraxins. Neuronal pentraxin (NP) receptor binds to taipoxin and taipoxin-associated calcium-binding protein 49 via NP1 and NP2. J. Biol. Chem. 2000, 275, 17786-17792.
33. Nielsen, H., Engelbrecht, J., Brunak, S., von Heijne, G., Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng. 1997, 10, 1-6.
34. Bendtsen, J. D., Nielsen, H., von Heijne, G., Brunak, S., Improved prediction of signal peptides: SignalP 3.0. J. Mol. Biol. 2004, 340, 783-795.
35. Jensen, P. H., Moestrup, S. K., Sottrup-Jensen, L., Petersen, C. M., Gliemann, J., Receptors for alpha 2-macroglobulin- and pregnancy zone protein-proteinase complexes in the human placental syncytiotrophoblast. Placenta 1988, 9, 463-477.
36. Honoré, B., Vorum, H., Pedersen, A. E., Buus, S., Claësson, M. H., Changes in protein expression in p53 deleted spontaneous thymic lymphomas. Exp. Cell Res. 2004, 295, 91-101.
37. Østergaard, M., Hansen, G. A., Vorum, H., Honoré, B., Proteomic profiling of fibroblasts reveals a modulating effect of extracellular calumenin on the organization of the actin cytoskeleton. Proteomics 2006, 6, 3509-3519.
38. Honoré,B., Buus, S., Claësson, M. H., Identification of differentially expressed proteins in spontaneous thymic lymphomas from knockout mice with deletion of p53. Proteome Sci. 2008, 6, 18.
39. Benjamin, D., Schmidlin, M., Min, L., Gross, B., Moroni, C., BRF1 protein turnover and mRNA decay activity are regulated by protein kinase B at the same phosphorylation sites. Mol. Cell. Biol. 2006, 26, 9497-9507.
40. Maunsbach, A. B., Vorum, H., Kwon, T. H., Nielsen, S. et al. Immunoelectron microscopic localization of the electrogenic Na/HCO(3) cotransporter in rat and ambystoma kidney. J. Am. Soc. Nephrol. 2000, 11, 2179-2189.
41. 2+-dependent association of S100A6 (Calcyclin) with the plasma membrane and the nuclear envelope. J. Biol. Chem. 1999, 274, 31593-31596.
42. Davis 3rd. A. E. Hereditary and acquired deficiencies of C1 inhibitor. Immunodefic. Rev. 1989, 1, 207-226.
43. Johnson, J. M., Castle, J., Garrett-Engele, P., Kan, Z. et al. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 2003, 302, 2141-2144.
44. Kochetov, A. V., Alternative translation start sites and hidden coding potential of eukaryotic mRNAs. Bioessays 2008, 30, 683-691.
45. Wang, Y., Dun, S. L., Huang, P., Chen, C. et al. Distribution and ultrastructural localization of GEC1 in the rat CNS. Neuroscience 2006, 140, 1265-1276.
46. Mansuy, V., Boireau, W., Fraichard, A., Schlick, J. L. et al. GEC1, a protein related to GABARAP, interacts with tubulin and GABA(A) receptor. Biochem. Biophys. Res. Commun. 2004, 325, 639-648.
47. Deloulme, J. C., Assard, N., Mbele, G. O., Mangin, C. et al. S100A6 and S100A11 are specific targets of the calcium- and zinc-binding S100B protein in vivo. J. Biol. Chem. 2000, 275, 35302-35310.
48. Courtois-Coutry, N., Le Moellic, C., Boulkroun, S., Fay, M. et al. Calcyclin is an early vasopressin-induced gene in the renal collecting duct. Role in the long term regulation of ion transport. J. Biol. Chem. 2002, 277, 25728-25734.
49. Tomas, A., Moss, S. E., Calcium- and cell cycle-dependent association of annexin 11 with the nuclear envelope. J. Biol. Chem. 2003, 278, 20210-20216.
50. Farnaes, L., Ditzel, H. J., Dissecting the cellular functions of annexin XI using recombinant human annexin XI-specific autoantibodies cloned by phage display. J. Biol. Chem. 2003, 278, 33120-33126.
51. Hsieh, H. L., Schafer, B. W., Sasaki, N., Heizmann, C. W., Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays. Biochem. Biophys. Res. Commun. 2003, 307, 375-381.
52. Mueller, A., Bachi, T., Hochli, M., Schafer, B. W., Heizmann, C. W., Subcellular distribution of S100 proteins in tumor cells and their relocation in response to calcium activation. Histochem. Cell Biol. 1999, 111, 453-459.
53. 2+ in sarcoplasmic reticulum in perfused rabbit heart loaded with 1,2-bis(2-amino-5,6-difluorophenoxy)ethane-N,N,N′, N′-tetraacetic acid by 19F NMR. J. Biol. Chem. 1996, 271, 7398-7403.
54. 2+ oscillations. Proc. Natl. Acad. Sci. USA 1994, 91, 9750-9754.
55. Antonenkov, V. D., Dehydrogenases of the pentose phosphate pathway in rat liver peroxisomes. Eur. J. Biochem. 1989, 183, 75-82.
56. Furthmayr, H., Lankes, W., Amieva, M., Moesin, a new cytoskeletal protein and constituent of filopodia: its role in cellular functions. Kidney Int. 1992, 41, 665-670.
57. Egerton, M., Burgess, W. H., Chen, D., Druker, B. J. et al. Identification of ezrin as an 81-kDa tyrosine-phosphorylated protein in T cells. J. Immunol. 1992, 149, 1847-1852.
58. Wilgenbus, K. K., Milatovich, A., Francke, U., Furthmayr, H., Molecular cloning, cDNA sequence, and chromosomal assignment of the human radixin gene and two dispersed pseudogenes. Genomics 1993, 16, 199-206.
59. Barwise, J. L., Walker, J. H., Subcellular localization of annexins in human foreskin fibroblasts. Biochem. Soc. Trans. 1995, 23, 35S.
60. Matteo, R. G., Moravec, C. S., Immunolocalization of annexins IV, V and VI in the failing and non-failing human heart. Cardiovasc. Res. 2000, 45, 961-970.
61. Mulla, A., Christian, H. C., Solito, E., Mendoza, N. et al. Expression, subcellular localization and phosphorylation status of annexins 1 and 5 in human pituitary adenomas and a growth hormone-secreting carcinoma. Clin. Endocrinol. (Oxf) 2004, 60, 107-119.
62. Vermes, I., Haanen, C., Steffens-Nakken, H., Reutelingsperger, C., A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods 1995, 184, 39-51.
63. Wang, X., Campos, B., Kaetzel, M. A., Dedman, J. R., Secretion of annexin V from cultured cells requires a signal peptide. Placenta 2001, 22, 837-845.
64. Reutelingsperger, C. P., Hornstra, G., Hemker, H. C., Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord. Eur. J. Biochem. 1985, 151, 625-629.
65. Hofmann, B., Hecht, H. J., Flohe, L., Peroxiredoxins. Biol. Chem. 2002, 383, 347-364.
66. Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000, 25, 25-29.
67. Campbell, T., Skilton, R. A., Coombes, R. C., Shousha, S. et al. Isolation of a lactoferrin cDNA clone and its expression in human breast cancer. Br. J. Cancer 1992, 65, 19-26.
68. Kanyshkova, T. G., Buneva, V. N., Nevinsky, G. A., Lactoferrin and its biological functions. Biochemistry (Mosc) 2001, 66, 1-7.
69. Brock, J. H., The physiology of lactoferrin. Biochem. Cell Biol. 2002, 80, 1-6.
70. Masschalck, B., Michiels, C. W., Antimicrobial properties of lysozyme in relation to foodborne vegetative bacteria. Crit. Rev. Microbiol. 2003, 29, 191-214.
71. Manevich, Y., Fisher, A. B., Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism. Free Radic. Biol. Med. 2005, 38, 1422-1432.
72. van Heerde, W. L., de Groot, P. G., Reutelingsperger, C. P., The complexity of the phospholipid binding protein Annexin V. Thromb. Haemost. 1995, 73, 172-179.
73. Campbell, D. J., Towards understanding the kallikrein-kinin system: insights from measurement of kinin peptides. Braz. J. Med. Biol. Res. 2000, 33, 665-677.
74. Spronk, H. M., Govers-Riemslag, J. W., ten Cate, H., The blood coagulation system as a molecular machine. Bioessays 2003, 25, 1220-1228.
75. 2+-dependent complex with thrombospondin-1. A potential role in haemostasis and thrombosis. Mol. Cell. Biochem. 2009, 320, 25-33.
76. Wallin, R., Hutson, S. M., Warfarin and the vitamin K-dependent gamma-carboxylation system. Trends Mol. Med. 2004, 10, 299-302.
77. Cunningham, M. D., Desai, N. S., Charlet, S. S., Human milk for the premature infant. Female Patient 1979, 4, 29-32, 34.
78. Takizawa, T., Robinson, J. M., Use of 1.4-nm immunogold particles for immunocytochemistry on ultra-thin cryosections. J. Histochem. Cytochem. 1994, 42, 1615-1623.
79. Goldberg, G. S., Kunimoto, T., Alexander, D. B., Suenaga, K. et al. Full length and delta lactoferrin display differential cell localization dynamics, but do not act as tumor markers or significantly affect the expression of other genes. Med. Chem. 2005, 1, 57-64.
80. Haversen, L., Ohlsson, B. G., Hahn-Zoric, M., Hanson, L. A., Mattsby-Baltzer, I., Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NFkappa B. Cell. Immunol. 2002, 220, 83-95.
81. Ohe, Y., Ishikawa, K., Itoh, Z., Tatemoto, K., Cultured leptomeningeal cells secrete cerebrospinal fluid proteins. J. Neurochem. 1996, 67, 964-971.
82. Schmaier, A. H., Zuckerberg, A., Silverman, C., Kuchibhotla, J. et al. High-molecular weight kininogen. A secreted platelet protein. J. Clin. Invest. 1983, 71, 1477-1489.
83. Blaker, M., Kock, K., Ahlers, C., Buck, F., Schmale, H., Molecular cloning of human von Ebner's gland protein, a member of the lipocalin superfamily highly expressed in lingual salivary glands. Biochim. Biophys. Acta 1993, 1172, 131-137.
84. Kittler, J. T., Rostaing, P., Schiavo, G., Fritschy, J. M. et al. The subcellular distribution of GABARAP and its ability to interact with NSF suggest a role for this protein in the intracellular transport of GABA(A) receptors. Mol. Cell. Neurosci. 2001, 18, 13-25.
85. Immenschuh, S., Baumgart-Vogt, E., Peroxiredoxins, oxidative stress, and cell proliferation. Antioxid. Redox Signal 2005, 7, 768-777.
86. Oberley, T. D., Verwiebe, E., Zhong, W., Kang, S. W., Rhee, S. G., Localization of the thioredoxin system in normal rat kidney. Free Radic. Biol. Med. 2001, 30, 412-424.
87. Mandinova, A., Atar, D., Schafer, B. W., Spiess, M. et al. Distinct subcellular localization of calcium binding S100 proteins in human smooth muscle cells and their relocation in response to rises in intracellular calcium. J. Cell Sci. 1998, 111 (Pt 14), 2043-2054.
88. Dowen, S. E., Crnogorac-Jurcevic, T., Gangeswaran, R., Hansen, M. et al. Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer. Am. J. Pathol. 2005, 166, 81-92.
89. Wang, G., Platt-Higgins, A., Carroll, J., de Silva Rudland, S. et al. Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients. Cancer Res. 2006, 66, 1199-1207.
90. 2+- dependent binding and activation of dormant ezrin by dimeric S100P. Mol. Biol. Cell 2003, 14, 2372-2384.
91. Franck, Z., Gary, R., Bretscher, A., Moesin, like ezrin, colocalizes with actin in the cortical cytoskeleton in cultured cells, but its expression is more variable. J. Cell Sci. 1993, 105 (Pt 1), 219-231.
92. Morand, S., Buchillier, V., Maurer, F., Bonny, C. et al. Induction of apoptosis in human corneal and HeLa cells by mutated BIGH3. Invest. Ophthalmol. Vis. Sci. 2003, 44, 2973-2979.
93. Wang, X., Kaetzel, M. A., Yoo, S. E., Kim, P. S., Dedman, J. R., Ligand-regulated secretion of recombinant annexin V from cultured thyroid epithelial cells. Am. J. Physiol. Cell Physiol. 2002, 282, C1313-C1321.
94. Sutton, V. R., Waterhouse, N. J., Baran, K., Browne, K., Measuring cell death mediated by cytotoxic lymphocytes or their granule effector molecules. Methods 2008, 44, 241-249.